SCHEMBL7090170

SCHEMBL7090170

CCOC(=O)Cc1ccc2ccccc2c1S(=O)(=O)Nc1ccc2c(c1)CCCN2C(=O)COc1ccc(C#N)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.45
BRD4 O60885 1/20 0.42
CREBBP Q92793 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
OGG1 O15527 2/20 0.41
NR3C1 P04150 4/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 2/20 0.40
TP53 P04637 2/20 0.40
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985832 0.83 NR3C1 (0.46) MAPTBRD4CREBBPSMN1; SMN2OGG1
SCHEMBL6980538 0.79 NR3C1 (0.56) MAPTSMN1; SMN2OGG1NR3C1ALDH1A1
SCHEMBL6987762 0.77 BRD4 (0.48) MAPTBRD4CREBBPSMN1; SMN2NR3C1
SCHEMBL6977885 0.71 NR3C1 (0.48) BRD4CREBBPSMN1; SMN2NR3C1TSHR
SCHEMBL6984100 0.71 TP53 (0.41) MAPTSMN1; SMN2ALDH1A1HPGDTP53
SCHEMBL6982160 0.70 NR3C1 (0.61) MAPTSMN1; SMN2NR3C1ALDH1A1LMNA
Hydrochloric Acid SCHEMBL6984176 0.69 NR3C1 (0.55) MAPTSMN1; SMN2OGG1NR3C1ALDH1A1
SCHEMBL6981976 0.69 NR3C1 (0.44) BRD4CREBBPSMN1; SMN2NR3C1
SCHEMBL6985835 0.69 SLC16A3 (0.42) MAPTSMN1; SMN2ALDH1A1TP53LMNA
Iodide SCHEMBL7960088 0.69 ALDH1A1 (0.41) MAPTBRD4CREBBPSMN1; SMN2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed